Medical Imaging in New York

Positrigo AG is a Swiss medical imaging company specializing in dedicated brain Positron Emission Tomography (PET) systems. The company manufactures the NeuroLF, an ultra-compact, fully integrated brain PET scanner designed to make functional neuroimaging accessible and affordable for precision medicine applications. The NeuroLF system is particularly focused on early diagnosis of neurodegenerative diseases, including Alzheimer's disease and other dementia-related disorders. The company has achieved FDA clearance (July 2024) and CE Mark (October 2024) for its NeuroLF system, enabling commercialization in the US and Europe. Positrigo holds ISO 13485:2016 certification, demonstrating compliance with medical device quality management standards. The company manufactures and distributes its systems through a network of international distributors across Europe, the US, and other regions. Recent deployments include installations at The Neuron Clinic (first US outpatient neurology clinic), Beverly Hills Medical Imaging, University Hospital of Genoa (Italy), and LMU Hospital Munich (Germany). Positrigo operates a US subsidiary established in 2023 and launched the BrainPET Accelerator program in the US to support clinical adoption. The company is backed by significant venture funding and has received grants from Innosuisse and the European Innovation Council (EIC Fund).

Imagen is an AI-enabled diagnostic imaging partner delivering teleradiology, on-site imaging equipment, and FDA-cleared AI software to independent practices, hospitals, and health systems nationally. The company operates a network of 95+ board-certified radiologists and sub-specialists across 50 states (active licenses), serving 3.5 million patients in 23 states. Core offerings include: (1) In-Clinic Imaging—permanent, in-office diagnostic imaging equipment with end-to-end support and program deployment; (2) AI-Enabled Interpretations—U.S.-based subspecialized clinicians augmented with proprietary FDA-cleared AI algorithms for improved diagnostic accuracy, consistency, and turnaround time; (3) Advanced Imaging Analytics (RadGap)—AI-driven image and report analytics for payers, providers, and risk-bearing entities to identify and close care gaps. The company positions itself as a partnership model between diagnosticians and ordering physicians, emphasizing 24/7 support, rapid turnaround, and clinical outcomes: 73% reduction in life-threatening misses (chest imaging), 100% improvement in chronic disease identification, and 97% all-time customer retention. Imagen manufactures or deploys diagnostic imaging hardware on-site and develops AI software for image interpretation and population health analytics. FDA clearances include AI algorithms; specific regulatory pathways (510(k), De Novo) not detailed in available content.

Carestream Health is a global medical imaging company headquartered in Rochester, New York, with approximately 3,500–5,000 employees and annual revenue of ~$1.5 billion. Originally spun from Eastman Kodak's Health Group in 2007 and now owned by Onex Corporation, Carestream specializes in digital radiography systems, mobile X-ray solutions, and advanced healthcare IT platforms including PACS and RIS. The company delivers diagnostic imaging equipment for medical applications—including pediatric and orthopedic imaging—as well as computed radiography and cone-beam CT technologies. Carestream also serves industrial non-destructive testing markets and provides precision contract coating services. Known for innovation in image quality, noise reduction, and dose optimization, the company partners with healthcare providers globally to improve diagnostic confidence and operational efficiency through cutting-edge imaging solutions and clinical software.

Aidoc is a healthcare AI software company founded in 2016, providing clinical decision support solutions built on its proprietary aiOS™ platform. The company delivers AI-powered medical imaging analysis and clinical intelligence tools across radiology, cardiology, neurovascular, and vascular care specialties. Aidoc's algorithms automatically analyze medical imaging (primarily CT scans) to detect acute pathologies, identify incidental findings, and prioritize critical cases for rapid clinical intervention. The platform integrates with hospital workflows to improve notification time-to-treatment, enhance care team coordination, and optimize patient management across departments. Serving over 1,600 medical centers globally and analyzing imaging for approximately 45 million patients annually, Aidoc enables healthcare systems to cover approximately 75% of their patient populations with AI-assisted clinical decision support. Key clinical applications include stroke detection and door-to-puncture time reduction, pulmonary embolism prioritization, cardiac disease measurement, and vascular pathology management.

MRIguidance develops BoneMRI, a medical imaging software solution that generates 3D CT-like images of bone structures derived from standard MRI scans. The technology eliminates the need for ionizing radiation exposure while providing diagnostic-quality bone visualization, eliminating duplicate imaging procedures and reducing patient hospital visits. BoneMRI integrates seamlessly with clinical workflows through automatic image reconstruction and PACS forwarding, compatible with major MRI scanner platforms from GE, Siemens, and Philips. The solution serves orthopedic surgery, spine surgery, and surgical navigation applications across cervical, thoracic, lumbar spine, and pelvic anatomies. Intended for adult, adolescent, and pediatric patient populations, BoneMRI supports diagnostic imaging, surgical navigation and planning, and research applications. The company holds trademark registrations in the US, UK, and EU. Recent product updates include stitching functionality and expanded scanner compatibility. Founded as a European company and operating a US entity, MRIguidance markets to academic medical centers and specialty surgical hospitals.